HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-octanoylglucosylceramide

Also Known As:

N-octanoyl-glucosylceramide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Gueth, D M: 1 article (09/2014)
2.	Klymchenko, A: 1 article (09/2014)
3.	Koning, G A: 1 article (09/2014)
4.	Verheij, M: 1 article (09/2014)
5.	van Blitterswijk, W J: 1 article (09/2014)
6.	van Hell, A J: 1 article (09/2014)
7.	Dicheva, Bilyana M: 1 article (01/2011)
8.	Eggermont, Alexander M M: 1 article (01/2011)
9.	Koning, Gerben A: 1 article (01/2011)
10.	Schipper, Debby: 1 article (01/2011)

Related Diseases

1.

Neoplasms (Cancer)

01/01/2011 - "Previously, we discovered that preinsertion of short-chain sphingolipids such as N-octanoyl-glucosylceramide (GC) in the tumor cell membrane enhances cellular Dox uptake. "
09/01/2014 - "For example, short-chain sphingolipids (SCS), like N-octanoyl-glucosylceramide, effectively elevated doxorubicin accumulation in tumor cells, both in vitro and in vivo, and in endothelial cells, whereas other (normal) cells remained unaffected. "

Related Drugs and Biologics

1.	Sphingolipids
2.	Doxorubicin (Adriamycin)